MARCIA DEABREU: Open Payments
NPI 1316671431 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 29 payments from 13 companies in 2025. Trend: 2023 $32 · 2024 $0 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $103 |
| Lilly USA, LLC | 4 | $79 |
| Verity Pharmaceuticals Inc. | 3 | $67 |
| Novo Nordisk Inc | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| TOLMAR, INC. | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $39 |
| Bausch Health US, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: BOTOX, MOUNJARO, Tlando, Saxenda, Kerendia, JATENZO, Auvelity, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
